Drug Type Small molecule drug |
Synonyms MoxiDex Otic, Moxifloxacin/dexamethasone, VIGADEXA + [3] |
Mechanism Bacterial DNA gyrase inhibitors, GR agonists(Glucocorticoid receptor agonists), Topoisomerase IV inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC21H25ClFN3O4 |
InChIKeyIDIIJJHBXUESQI-DFIJPDEKSA-N |
CAS Registry186826-86-8 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Eye Infections | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cataract | Phase 3 | - | 01 Mar 2014 | |
Acute transudative otitis media | Phase 3 | US | 01 Feb 2010 | |
Otitis Media | Phase 3 | - | 01 Dec 2005 | |
Ocular inflammation | Phase 2 | BR | 27 Feb 2020 | |
Keratitis | Phase 2 | US | 01 Dec 2007 | |
Post procedural inflammation | Phase 1 | CN | 17 Mar 2023 | |
Post procedural inflammation | Phase 1 | CN | 17 Mar 2023 |
Phase 4 | 36 | ttqqwtmzws(auezikcgyb) = pqcpldkyct krrxazipvy (tionwwqqto, mpjiodpvzh - novvfmtdwp) View more | - | 07 Aug 2013 | |||
Phase 4 | 64 | pkusqaaext(wfsbtvsgma) = hkrvhgqvtc lafvwmwjiu (nqqacfnpfd, ytgmlblucd - zncexbuzra) View more | - | 15 Feb 2010 |